Clindamycin Phosphate and Tretinoin
Links shared publicly online about this topic
Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%
drugs.com — “Veltin (clindamycin phosphate and tretinoin) Gel is used to treat acne vulgaris. Includes Veltin side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 17, 2010 at 6:00 am By:
Drugs and Devices OW OW Health
Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%: Res... http://bit.ly/cVQq69
Stiefel, a GSK company, Receives FDA Approval of Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025%
drugs.com — “Veltin (clindamycin phosphate and tretinoin) Gel is used to treat acne vulgaris. Includes Veltin side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 16, 2010 at 8:48 pm By:
FDA Approves Veltin (clindamycin phosphate and tretinoin) Gel 1.2%/0.025% - http://bit.ly/b0H98T
Acanya(TM) Gel, A New Treatment For Moderate To Severe Acne, Launched By Coria Laboratories
medicalnewstoday.com — “Coria Laboratories, the newly expanded dermatology division of Valeant Pharmaceuticals International (NYSE: VRX), announced the commercial launch of Acanya(TM) Gel (clindamycin phosphate 1.2% and” View full resource at medicalnewstoday.com
Most Recently Shared on March 7, 2009 at 12:28 pm By:
John L LeRoy Jr MD Surgeon, Plastic Surgeon, Physician, and Doctor
http://bit.ly/Qf2sX Acanya(TM) Gel, A New Treatment For Moderate To Severe Acne, Launched By Coria Laboratories
Infectious Disease Article | Acne Vulgaris
mdlinx.com — “Topical management of acne vulgaris using a combination gel formulation: benzoyl peroxide 2.5%--clindamycin phosphate 1.2% gel” View full resource at mdlinx.com
Most Recently Shared on December 14, 2010 at 2:37 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Topical management of acne vulgaris using a combination gel formulation: benzoyl peroxide 2.5%–clindamycin p... http://bit.ly/fXMADm #ID
FDA approves Stiefel's acne drug Veltin - Related Stories - AAP SmartBrief
smartbrief.com — “The FDA approved Stiefel's Veltin, a topical treatment for acne vulgaris in patients age 12 and older. Veltin, which is a water-based gel, contains tretinoin and clindamycin phosphate. <a href='/servlet/aaRedirect?url2=http%3a%2f%2fwww%2emodernmedicine%2ecom%2fmodernmedicine%2fAcne%2fFDA%2dOKs%2dSti” View full resource at smartbrief.com
Most Recently Shared on August 5, 2010 at 2:26 pm By:
Clara Song Pediatrician, Physician, and Doctor
FDA approves Stiefel's acne drug Veltin http://sbne.ws/r/5igy
Perrigo, Cobrek Pharmaceuticals receive FDA approval for generic Evoclin Foam 1%
news-medical.net — “Perrigo Company today announced that together with its partner Cobrek Pharmaceuticals, Inc. final approval has been received from the U.S. Food and Drug Administration to manufacture and market Clindamycin Phosphate Foam 1%, a generic version of Evoclin® Foam 1% of Stiefel. As the ANDA was first to file with a Paragraph IV certification against Evoclin®, 180 days of generic exclusivity was granted by the U.S. Food and Drug Administration.” View full resource at news-medical.net
Most Recently Shared on April 5, 2010 at 4:02 pm By:
Perrigo, Cobrek Pharmaceuticals receive FDA approval for generic Evoclin Foam 1%: Perrigo Company today announced ... http://bit.ly/dzndJs
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
John L LeRoy Jr MD
Band Aid Mini Facelift -- Board Certified Plastic Surgeon Specialty Trained in Cosmetic Plastic Surgery ---------- facebook.com/johnleroymd - Tel:404-843-0840
Advertisement
